Work

Can patient-reported kidney cancer–specific symptoms at baseline serve as an indicator for median progression-free and overall survival in sorafenib-refractory metastatic renal cell carcinoma?

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.6136

Authors: P. C. Trask, A. G. Bushmakin, J. C. Cappelleri, J. C. Tarazi, B. Rosbrook, P. W. Bycott, S. Kim, W. M. Stadler, B. I. Rini

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W162196649

Cites:

Cited by: 1

Related to: 10